National Surveillance of Nosocomial Blood Stream Infection Due to Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

An overview of nosocomial infections, including the role of the microbiology laboratory

1993 • 1,266 citations

Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990

1993 • 1,164 citations

The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in Adults

1997 • 1,159 citations

Major trends in the microbial etiology of nosocomial infection

1991 • 1,131 citations

Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989

1991 • 896 citations

Resistance of Candida species to fluconazole

1995 • 890 citations

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

1997 • 862 citations

Hospital-Acquired Candidemia

1988 • 835 citations

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1996 • 779 citations

The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species

1997 • 774 citations

Epidemiology of nosocomial fungal infections

1996 • 765 citations

Importance of Candida Species Other than C. albicans as Pathogens in Oncology Patients

1995 • 562 citations

Nosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of Transmission

1996 • 521 citations

Update on detection of bacteremia and fungemia

1997 • 459 citations

Antimicrobial Resistance in Isolates from Inpatients and Outpatients in the United States: Increasing Importance of the Intensive Care Unit

1997 • 443 citations

National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

1998 • 427 citations

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1995 • 303 citations

Microbiological Factors Influencing the Outcome of Nosocomial Bloodstream Infections: A 6‐Year Validated, Population‐Based Model

1997 • 303 citations

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1994 • 241 citations

HOSPITAL ACQUIRED INFECTIONS

2010 • 238 citations

Hospital-acquired infections: diseases with increasingly limited therapies.

1994 • 234 citations

Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis

1994 • 205 citations

Hospital-acquired candidemia. The attributable mortality and excess length of stay

1988 • 194 citations

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

1996 • 168 citations

Opportunistic Candidiasis: An Epidemic of the 1980s

1995 • 160 citations

Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals

1996 • 135 citations

Hospital Specificity, Region Specificity, and Fluconazole Resistance of Candida albicans Bloodstream Isolates

1998 • 95 citations

In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp

1995 • 41 citations

In vitro Susceptibility of Fungal Isolates of Clinically Important Specimens to Itraconazole, Fluconazole and Amphotericin B

1994 • 41 citations

In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method

1995 • 36 citations

Fluconazole, Itraconazole and KetoconazoleIn VitroActivity againstCandidaspp.

1994 • 21 citations